GLP-1 receptor agonists like semaglutide do not simply help women lose weight and call it a day
It can involve insulin resistance, higher androgen levels, acne, facial hair growth, irregular ovulation, weight gain, inflammation, cholesterol changes, blood sugar problems, fatty liver risk, and increased cardiovascular risk
Key Takeaways 24.2% weight loss at 48 weeks with 12mg dose, the highest efficacy seen in any GLP-1 class medication trial 93% of participants on 12mg achieved 15% weight loss
GLP-1 receptor sensitivity Genetic variation in GLP-1 receptor expression and sensitivity influences how strongly any individual responds to semaglutide
Our clinicians assess your medical history and help you decide whether out treatment can help you on your weight loss journey